A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
California was already contending with a home insurance crisis due to unpredictable weather events. Then came this week’s fires.
England had a rude awakening this week, as the United Kingdom was transported back in time to one of the most tumultuous years in its history.
Defined outcome ETFs have long promised virtually risk-free investing, but also place significant caps on potential gains.